Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

United States — Food and Drug Administration

Tracked across 734 events · 12908 articles · First seen Jan 04, 2025 · Last active Sep 24, 2026

Sentiment
5
Attention
9
Events
734
Relationships
402
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
3 70
Regulatory
Impact: The United States — Food and Drug Administration launched the 'Read the Food Label Campaign' to empower consumers and reduce diet-related non-communicable diseases in Nigeria. This initiative enhances its role in public health protection.
Jun 26, 2026 · 7 articles
4 60
Regulatory
Impact: The FDA granted the supplemental approval, expanding Casgevy's indication to younger patients, and utilized expedited review programs.
Jul 01, 2026 · 6 articles
1 0
Regulatory
Impact: The FDA conducted the study and concluded tampon metals are safe, reinforcing its regulatory role. It also proposed new guidelines for tampon manufacturers.
Jul 07, 2026 · 6 articles
1 80
Domestic
Impact: NAFDAC is the central entity; its transformation under Adeyeye's leadership is the focus of the award. The agency's improved regulatory status enhances its credibility and operational capacity.
Jul 08, 2026 · 6 articles
2 10
Regulatory
Impact: NAFDAC enforces regulatory compliance, strengthening its reputation as a vigilant regulator.
Jul 20, 2026 · 6 articles
3 0
Regulatory
Impact: The FDA is the central regulator; its decision on peptide compounding will set the regulatory framework.
Jul 22, 2026 · 47 articles
2 10
Regulatory
Impact: NAFDAC is the lead enforcer of the federal ban, conducting nationwide raids and seizures. The operation reinforces its regulatory authority and public health mandate.
Jul 22, 2026 · 47 articles
7 -10
Accidents
Impact: The FDA led the investigation, linking the outbreak to Taylor Farms lettuce. It faced criticism for a false-positive test result and for potential influence by the United States — White House, but it continues to work on the investigation.
Jul 08, 2026 · 358 articles
7 60
Regulatory
Impact: The FDA granted approval for mFLUSIVA, marking a regulatory milestone and demonstrating its role in vaccine oversight despite internal controversies.
Aug 05, 2026 · 105 articles
4 20
Regulatory
Impact: The FDA is the central regulator proposing the new notification requirement and completing the ultraprocessed food definition, enhancing its oversight role.
Aug 10, 2026 · 12 articles
1 10
Regulatory
Impact: NAFDAC is the central regulator; it retracted the alert, conducted the investigation, and reaffirmed product safety, reinforcing its role in ensuring drug quality.
Aug 14, 2026 · 6 articles
4 -10
Regulatory
Impact: Regulatory authority that upgraded the egg recall to Class 1 and is investigating the outbreaks; its actions drive the recall process.
Aug 14, 2026 · 6 articles
6 -40
Domestic
Impact: The FDA is the agency being led. It faces staff losses, morale issues, and policy controversies; Overton's nomination could exacerbate these challenges.
Aug 19, 2026 · 101 articles
4 -40
Regulatory
Impact: The FDA is the central regulator whose clearance process is criticized for not requiring outcome testing. The study could lead to policy changes affecting its approval pathways.
Aug 19, 2026 · 6 articles
4 0
Regulatory
Impact: The FDA granted clearance to the Elecsys pTau217 blood test, a regulatory action that enables U.S. marketing and use of the test.
Aug 24, 2026 · 7 articles
4 60
Regulatory
Impact: The FDA granted approval for the first mRNA flu vaccine, a regulatory milestone that validates the safety and efficacy of mRNA technology for seasonal influenza prevention.
Aug 06, 2026 · 6 articles
4 20
Regulatory
Impact: NAFDAC is the primary regulator enforcing the ban, ordering recalls, closing facilities, and imposing sanctions. Its actions directly affect the alcoholic beverage industry in Nigeria.
Aug 24, 2026 · 20 articles
4 0
Regulatory
Impact: The FDA is the subject of the restructuring, which could reshape its leadership and regulatory approach, affecting drug approvals and AI oversight.
Aug 25, 2026 · 6 articles
4 60
Regulatory
The U.S. United States — Food and Drug Administration (FDA) authorized the Aletta, the first standalone robotic device that can autonomously draw blood from a patient's arm. The device, made by Dutch medical robotics company…
Impact: The FDA granted De Novo authorization to the Aletta device, marking a regulatory milestone that could pave the way for similar autonomous medical devices.
Aug 19, 2026 · 21 articles
7 80
Regulatory
Impact: The FDA granted expedited approval to daraxonrasib, marking a regulatory milestone and demonstrating its commitment to accelerating cancer treatments. The approval was issued 6.5 months ahead of schedule, reflecting the agency's priority review process.
Aug 26, 2026 · 92 articles
2 60
Regulatory
NAFDAC's 5+5 Policy and Ceiling List initiatives, introduced in 2019 and expanded since, have significantly reshaped Nigeria's pharmaceutical industry by restricting imports of medicines that can be produced locally. According to NAFDAC Director-General Mojisola Adeyeye,…
Impact: NAFDAC is the central regulator implementing the 5+5 Policy and Ceiling List, driving the shift to local manufacturing. Its actions have increased its regulatory influence and are seen positively for domestic industry.
Sep 06, 2026 · 6 articles
4 10
Regulatory
On August 31, 2026, the United States — United States Securities and Exchange Commission (SEC) and the United States — Food and Drug Administration (FDA) signed a Memorandum of Understanding (MOU) establishing a formal framework…
Impact: The FDA formalizes cooperation with the SEC, enhancing its role in referring potential securities violations and supporting market integrity, while maintaining confidentiality controls.
Aug 31, 2026 · 6 articles
2 10
Regulatory
On September 8, 2026, the U.S. Department of Health and Human Services announced the permanent appointment of four senior officials at the United States — Food and Drug Administration, filling roles that had been occupied…
Impact: The FDA gains permanent leadership in key centers, restoring stability after months of turnover. This affects its regulatory operations and relationships with regulated industries.
Sep 08, 2026 · 6 articles
1 10
Regulatory
The United States — Food and Drug Administration inaugurated a 600-member Pharmacists Reserve Volunteer Programme (PRVP) to strengthen the fight against substandard and falsified medicines and improve response to drug-related emergencies across Nigeria. Director-General Mojisola…
Impact: NAFDAC is the central actor, inaugurating the 600-member Pharmacists Reserve Volunteer Programme to expand its regulatory reach beyond laboratories and ports of entry. The initiative strengthens its enforcement capacity against substandard and falsified medicines across Nigeria.
Sep 13, 2026 · 6 articles
7 70
Regulatory
Impact: The United States — Food and Drug Administration (FDA) is the regulatory body responsible for approving the mFlusiva vaccine. Its advisory committee's unanimous recommendation is a crucial step towards the vaccine's market entry, despite internal disputes and leadership vacancies.
Jun 18, 2026 · 28 articles
4 -20
Regulatory
The United States — Food and Drug Administration has raised alarm over a shift in Nigeria's counterfeit goods trade, saying Chinese-led syndicates have moved from importing fake products into Nigeria to setting up manufacturing and…
Impact: Central agency in the event, leading the crackdown on counterfeit networks and facing criticism over alleged regulatory failure. Its credibility and leadership are under pressure from calls for its Director-General's removal.
Sep 08, 2026 · 26 articles
2 -5
Accidents
A mass poisoning crisis unfolded in Nigeria — Ondo State, Nigeria, after residents consumed locally brewed alcoholic and herbal concoctions. The United States — Food and Drug Administration confirmed high concentrations of methanol in the…
Impact: NAFDAC led the investigation, confirmed methanol and cannabis contamination, reported 48 deaths and 182 cases, and announced 15 arrests. The agency faces pressure to tighten regulation of unregulated beverages.
Jun 22, 2026 · 114 articles
6 0
Business
Impact: The United States — Food and Drug Administration accepted Pharvaris' New Drug Application for deucrictibant IR and set a PDUFA target action date of April 23, 2027. This action is a crucial step in the regulatory process for the drug's potential approval.
Jul 06, 2026 · 6 articles
4 0
Regulatory
Impact: The United States — Food and Drug Administration issued a Complete Response Letter to Galderma Group for RelabotulinumtoxinA, citing observations during a manufacturing site inspection and analytical method optimization, which delays the product's approval in the United States.
Jul 01, 2026 · 6 articles
6 0
Regulatory
Impact: The United States — Food and Drug Administration accepted the resubmission of the Biologics License Application for RP1, setting a target action date and scheduling an advisory committee meeting, which are crucial steps in the regulatory process for Replimune Group's drug.
Jun 26, 2026 · 8 articles
+ 704 more events View on Dashboard
+ 142 more actions View on Dashboard
Applied Therapeutics ↔ United States — Food and Drug Administration
Applied Therapeutics regulated ↔ United States — Food and Drug Administration Applied Therapeutics is a biopharmaceutical company strictly regulated by the FD
Viatris ↔ United States — Food and Drug Administration
Viatris ↔ United States — Food and Drug Administration
PepGen ↔ United States — Food and Drug Administration
PepGen ↔ United States — Food and Drug Administration
Rocket Pharmaceuticals ↔ United States — Food and Drug Administration
Rocket Pharmaceuticals ↔ United States — Food and Drug Administration
Savara ↔ United States — Food and Drug Administration
Dexcom ↔ United States — Food and Drug Administration
Savara ↔ United States — Food and Drug Administration
Dexcom ↔ United States — Food and Drug Administration
Kenvue ↔ United States — Food and Drug Administration
American College of Obstetricians and Gynecologists ↔ United States — Food and Drug Administration
Publix ↔ United States — Food and Drug Administration
Kenvue ↔ United States — Food and Drug Administration
American College of Obstetricians and Gynecologists ↔ United States — Food and Drug Administration
Publix ↔ United States — Food and Drug Administration
United States — National Park Service ↔ United States — Food and Drug Administration
United States — National Park Service ↔ United States — Food and Drug Administration
Actinium Pharmaceuticals ↔ United States — Food and Drug Administration
Actinium Pharmaceuticals ↔ United States — Food and Drug Administration
UniQure ↔ United States — Food and Drug Administration
UniQure ↔ United States — Food and Drug Administration
United States ↔ United States — Food and Drug Administration
United States ↔ United States — Food and Drug Administration
Eli Lilly and Company ↔ United States — Food and Drug Administration
Eli Lilly and Company ↔ United States — Food and Drug Administration
Knight Therapeutics ↔ United States — Food and Drug Administration
Knight Therapeutics ↔ United States — Food and Drug Administration
+ 372 more relationships View on Dashboard
ERGEN INTELLIGENCE
Track United States — Food and Drug Administration live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.